Addex to Present at the Virtual Sachs Associates 3rd Annual European HealthTech and 15th Annual European Life Sciences CEO Forums
Geneva, Switzerland, February 24, 2022 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage…
Year: 2022
argenx to Report Full Year 2021 Financial Results and Fourth Quarter Business Update on March 3, 2022
February 24, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
Bionomics’ Half-Year Report
ADELAIDE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (ASX: BNO, Nasdaq: BNOX), today…
Dante Labs selected as Genetic Tests provider for Abu Dhabi Executive Office Employee’s Wellbeing Week
Dante Labs meets with Abu Dhabi Executive Office Dante Labs CEO Andrea Riposati and Carlo…
Chargebee Acquires Numberz, Launches Receivables to Help Subscription Businesses Get Paid Faster
With latest acquisition, Chargebee helps recurring revenue businesses better manage their “money-in” with automated accounts…
Faraday Future Unveils First Production-Intent FF 91 EV Manufactured at its Hanford, Calif. Plant
With the first production-intent FF 91, Faraday Future has marked manufacturing Milestone #4 and remains…
Toshiba Launches Ultra-Low Capacitance TVS Diode That Protects High-Frequency Antennas of IoT Devices From ESD
KAWASAKI, Japan–(BUSINESS WIRE)–Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has launched “DF2B6M4BSL,” an ultra-low capacitance…
C3 ALERT: Bragar Eagel & Squire, P.C. Is Investigating C3.ai, Inc. on Behalf of C3 Stockholders and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#C3–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is…
Organigram Holdings Inc. Announces Election of Directors
BAT’s Simon Ashton Appointed to the Board of Directors MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc….
International Seaways to Announce Fourth Quarter and Full Year 2021 Results on March 2, 2022
NEW YORK–(BUSINESS WIRE)–International Seaways, Inc. (NYSE: INSW) (the “Company” or “INSW”) announced today that it…
Blue Water Vaccines Announces Closing of Initial Public Offering
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
U.S. FDA Licenses Certara’s Immunogenicity Simulator
Affirms the advancements of innovative biosimulation technology and its growing impact in R&D PRINCETON, N.J.,…
New Analysis Published in Peer-reviewed Psychiatry Research Shows Advantages of Combinatorial Algorithm of GeneSight® Psychotropic Test
Analysis shows combinatorial approach is more effective than single-gene testing at predicting sertraline metabolism in patients…
Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results
Reports Full-Year Net Revenue of $10.4 Million, a 22% Year-Over-Year Increase and Fourth Quarter Net Revenue…
GBT Reports Fourth Quarter and Full Year 2021 Financial Results
Achieved Oxbryta® (voxelotor) net revenues of $56.1 million in the fourth quarter and $194.7 million…
Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
— Company Expects to Announce Topline Results from the Phase 1/2 Study by the End of…
Orphazyme announces update on regulatory review of arimoclomol in the European Union
Orphazyme A/SCompany announcementNo. 07/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 23, 2022 – Orphazyme…
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE)…
Mary Agrotechnologies Inc. Reports First Quarter Fiscal 2022 Financial Results
Markham, Ontario–(Newsfile Corp. – February 23, 2022) – Mary Agrotechnologies Inc. (CSE: MARY) (OTCQB: MRRYF)…
Hyliion Holdings Reports Fourth Quarter and Full Year 2021 Financial Results
AUSTIN, Texas–(BUSINESS WIRE)–Hyliion Holdings Corp. (NYSE: HYLN) (“Hyliion”), a leader in electrified powertrain solutions for…